Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label on the page updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated to v3.4.2, replacing the prior v3.4.1.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check72 days agoChange DetectedA glossary feature was added to the page, and there are minor text/capitalization changes plus a new version label (Revision: v3.4.0). The core study content and user actions remain unchanged.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.